Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
0.7974
+0.0104 (1.32%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $25.02 million as of August 7, 2026. Its market cap has decreased by -49.86% in one year.
Market Cap
25.02M
Enterprise Value
-10.11M
1-Year Change
-49.86%
Ranking
Category
Stock Price
$0.80
ChartMarket Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $25.02M, an increase of 49.81%. That is a compound annual growth rate of 3.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 25.00M | -41.04% |
| Dec 31, 2025 | 42.40M | 7.89% |
| Dec 31, 2024 | 39.30M | -71.79% |
| Dec 29, 2023 | 139.30M | -48.67% |
| Dec 30, 2022 | 271.40M | 104.98% |
| Dec 31, 2021 | 132.40M | 24.91% |
| Dec 31, 2020 | 106.00M | 195.26% |
| Dec 31, 2019 | 35.90M | -19.87% |
| Dec 31, 2018 | 44.80M | -15.63% |
| Dec 29, 2017 | 53.10M | 8.81% |
| Dec 30, 2016 | 48.80M | -64.04% |
| Dec 31, 2015 | 135.70M | -23.20% |
| Dec 31, 2014 | 176.70M | 26.85% |
| Dec 31, 2013 | 139.30M | 734.13% |
| Dec 31, 2012 | 16.70M | - |
| Dec 27, 2012 | 16.70M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 29.53M |
| Kyntra Bio | 29.43M |
| Actuate Therapeutics | 26.44M |
| Tevogen | 26.37M |
| Evaxion | 25.85M |
| ABVC BioPharma | 25.78M |
| IGC Pharma | 25.68M |
| Barinthus Biotherapeutics | 24.47M |